Hepatitis & Tattoos: Think before You Ink
Links shared publicly online about this topic.
- 355total visits
Hepatitis & Tattoos: Think before You Ink
hepatitistattoos.blogspot.com —
View full resource at hepatitistattoos.blogspot.com
Tags: Liver Condition, Hepatitis
Most Recently Shared on April 18, 2011 at 9:13 pm By:
Tina Banwart - HepatitisCNewDrugs
Hepatitis & Tattoos: Think before You Ink http://bit.ly/ft83Bs
I.D. Hep C
identifyhepc.org — “Raise Awareness of Hepatitis C” View full resource at identifyhepc.org
Most Recently Shared on May 14, 2012 at 1:15 pm By:
Our new #IDHepC campaign is encouraging people to take a pledge to get educated about #hepC. http://t.co/yxQKgOga
Can Getting Sick Give You Cancer? New Research Says Sometimes, Yes - Forbes
forbes.com — “One sixth of all cases of cancer are caused by viruses and bacteria, new research says. Meaning they're preventable! If we know how.” View full resource at forbes.com
Most Recently Shared on May 11, 2012 at 12:13 am By:
Melanie Haiken, Health Writer Health Advocate
Yikes! Can bacteria and viruses lead to #cancer? New research says yes http://t.co/U9qVin2L via @sharethis @forbes #health #HPV #hepatitis
Reflections of a Living Liver Donor | Columbia University Department of Surgery Blog
columbiasurgery.net — “Living donation allows early life-saving transplant for liver disease patient with low MELD score.” View full resource at columbiasurgery.net
Most Recently Shared on May 9, 2012 at 7:35 am By:
Reflections of a Living Liver Donor: mother tells about donating part of her liver to her daughter. http://t.co/8tqBnuO6
New Projects Dispel Myths and Spread the Truth About Vaccines - IPS ipsnews.net
ipsnews.net — “In northern Pakistan, one in ten children dies before the age of five from diseases such as polio, measles or hepatitis, despite the availability of vaccines. And while health workers feared visiting this region, which includes the mountainous Swat district controlled by the Taliban until 2009, local people also fear the potentially life-saving vaccines.” View full resource at ipsnews.net
Most Recently Shared on May 4, 2012 at 3:36 am By:
New Projects Dispel Myths and Spread the Truth About Vaccines #humanrights http://t.co/naiUooju
Raising Awareness of Hepatitis B In the Asian and Pacific Islander Communities | blog.aids.gov
blog.aids.gov — “Raising Awareness of Hepatitis B In the Asian and Pacific Islander Communities | blog.aids.gov” View full resource at blog.aids.gov
Most Recently Shared on May 3, 2012 at 4:53 pm By:
RT @aidsgov: This month, join @HHSGov in raising awareness of #hepatitis B in Asian & Pacific Islander communities http://t.co/zGelKxwL
Hepatitis
kidshealth.org — “Hepatitis is most commonly caused by one of three viruses. In its early stages, hepatitis may cause flu-like symptoms.” View full resource at kidshealth.org
Most Recently Shared on May 1, 2012 at 6:15 pm By:
May is #Hepatitis Awareness Month: Find out how to protect your child. http://t.co/hEcZUKsu
AIDSmeds - Top Stories : FDA to Docs: Best to Avoid Victrelis With Norvir-Boosted HIV Protease Inhibitors - by Tim Horn
aidsmeds.com — “Victrelis (boceprevir), Merck?s hepatitis C virus (HCV) protease inhibitor, should not be combined with the following Norvir (ritonavir)-boosted HIV protease inhibitors: Reyataz (atazanavir), Prezista (darunavir) or Kaletra.” View full resource at aidsmeds.com
Most Recently Shared on April 30, 2012 at 1:13 pm By:
Top Stories - FDA to Docs: Best to Avoid Victrelis With Norvir-Boosted #HIV Protease Inhibitors http://t.co/VttAd4rH #hepatitis #HepC #AIDS
POZ - Treatment News : FDA to Docs: Best to Avoid Victrelis With Norvir-Boosted HIV Protease Inhibitors - by Tim Horn
poz.com — “Victrelis (boceprevir), Merck?s hepatitis C virus (HCV) protease inhibitor, should not be combined with the following Norvir (ritonavir)-boosted HIV protease inhibitors: Reyataz (atazanavir), Prezista (darunavir) or Kaletra.” View full resource at poz.com
Most Recently Shared on April 28, 2012 at 2:40 am By:
Health Literacy Medical School
Contentment Linked to Balanced View of One's Past, Present & Future - Not over valuing 1 > another http://t.co/LGB4FOTP @sciencedaily
Don't use boceprevir and ritonavir together, FDA says. - latimes.com
latimes.com — “FDA says don't use hepatitis drug Victrelis (boceprevir) and HIV drug ritonavir together.” View full resource at latimes.com
Most Recently Shared on April 27, 2012 at 5:03 pm By:
LA Times Health News Health News
FDA: Don't use certain hepatitis and HIV drugs together http://t.co/GlFqvx9R
SAFETY ALERT: Drug Interactions with Victrelis and Ritonavir-Boosted Protease Inhibitors - MPR
empr.com — “The FDA has notified healthcare professionals that drug interactions between the HCV protease inhibitor Victrelis and certain ritonavir-boosted HIV protease inhibitors can potentially reduce the effectiveness when they are used together.” View full resource at empr.com
Most Recently Shared on April 26, 2012 at 9:07 pm By:
#SAFETY ALERT: Drug Interactions with Victrelis and Ritonavir-Boosted Protease Inhibitors #HIV #hepatitis http://t.co/U2hWg9sq
Risk Of Early Atherosclerosis Increased By Fibrosis And Fatty Liver Disease
medicalnewstoday.com — “Italian researchers report that severe fibrosis increases the early atherosclerosis risk in patients with genotype 1 chronic hepatitis C virus (HCV) infection. A second study found that fatty live” View full resource at medicalnewstoday.com
Most Recently Shared on April 26, 2012 at 8:05 am By:
MNT Cardiovascular Health News
Risk Of Early Atherosclerosis Increased By Fibrosis And Fatty Liver Disease http://t.co/twKayCTv #cardiovascular
Elsevier
gastrojournal.org — “Elsevier” View full resource at gastrojournal.org
Most Recently Shared on April 26, 2012 at 12:55 am By:
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma: Most cases of hepatocellular carcinoma (HCC) are a... http://t.co/0P5Yf9fv
HCV New Drug Research: TGIF-2012 EASL Round-Up
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: TGIF-2012 EASL Round-Up” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on April 20, 2012 at 5:48 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
TGIF-EASL Round-Up http://t.co/r1wj3gXM
New data from descriptive sub-analysis of patients with compensated liver cirrhosis
news-medical.net — “New data from a descriptive sub-analysis of patients with compensated liver cirrhosis show that up to 43 percent of genotype-1a (GT1a) and up to 71 percent of GT1b hepatitis C virus (HCV) patients achieved sustained viral response (SVR12). SVR12 has been highly correlated with SVR24, which is a recognized indicator of viral cure.” View full resource at news-medical.net
Most Recently Shared on April 20, 2012 at 5:32 pm By:
HIV/AIDS News: New data from descriptive sub-analysis of patients with compensated liver cirrhosis: New data fro... http://t.co/TQDmTxG4
82% Hepatitis C Cure Rate Achieved In Large Trial
medicalnewstoday.com — “Up to 82% of patients with hepatitis C achieved viral cure after 28 weeks' treatment with a combination of Boehringer Ingelheim's investigational antiviral agents - the protease inhibi” View full resource at medicalnewstoday.com
Most Recently Shared on April 20, 2012 at 4:05 pm By:
82% Hepatitis C Cure Rate Achieved In Large Trial http://t.co/9XEo2TyV #healthnews
Advertisement
